Peregrine Ventures

Total investments

93

Average round size

9M

Portfolio companies

60

Rounds per year

4.04

Lead investments

3

Follow on index

0.33

Exits

11

Stages of investment
SeedEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareInformation TechnologyHealth CareHealth DiagnosticsRoboticsManufacturingMedical DeviceMedicalPersonal Health

Summary

Peregrine Ventures appeared to be the VC, which was created in 2001. The main department of described VC is located in the Or Yehuda. The company was established in Asia in Israel.

This organization was formed by Boaz Lifschitz, Eyal Lifschitz. We also calculated 3 valuable employees in our database.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Peregrine Ventures, startups are often financed by Accelmed, Elron Electronic Industries, Access Medical Ventures. The meaningful sponsors for the fund in investment in the same round are Pitango Venture Capital, Johnson & Johnson Innovation, Elron Electronic Industries. In the next rounds fund is usually obtained by Three Arch Partners, Pitango Venture Capital, ONSET Ventures.

Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has exact preference in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Social Media Marketing, Network Security. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Israel. Among the most popular portfolio startups of the fund, we may highlight CartiHeal, VisionCare Ophthalmic Technologies, Kailight Photonics.

The real fund results show that this VC is 10 percentage points less often commits exit comparing to other companies. Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year. The top amount of exits for fund were in 2016. The top activity for fund was in 2016. Despite it in 2019 the fund had an activity. Opposing the other organizations, this Peregrine Ventures works on 9 percentage points less the average amount of lead investments.

Show more

Investments analytics

Analytics

Total investments
93
Lead investments
3
Exits
11
Rounds per year
4.04
Follow on index
0.33
Investments by industry
  • Health Care (45)
  • Medical Device (26)
  • Biotechnology (23)
  • Medical (14)
  • Software (14)
  • Show 75 more
Investments by region
  • Israel (70)
  • United States (10)
  • Australia (1)
  • Canada (1)
  • Russia (1)
  • Show 2 more
Peak activity year
2018

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
9
Avg. valuation at time of investment
12M
Group Appearance index
0.38
Avg. company exit year
6
Avg. multiplicator
10.23

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Agridex 09 May 2024 Seed 5M England, London, United Kingdom
BioRefine 05 Jul 2019 Health Care Seed 200K
Blue White Robotics 23 Jan 2024 Automotive, Robotics, Autonomous Vehicles, Drones, AgTech, Agriculture Late Stage Venture 39M Tel Aviv District, Tel Aviv-Yafo, Israel

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.